Steeds RP - Search Results

1

A cross-sectional study of the prevalence of cardiac valvular abnormalities in hyperprolactinemic patients treated with ergot-derived dopamine agonists.

Drake WM, Stiles CE, Howlett TA, Toogood AA, Bevan JS, Steeds RP; UK Dopamine Agonist Valvulopathy Group. Drake WM, et al. Among authors: steeds rp. J Clin Endocrinol Metab. 2014 Jan;99(1):90-6. doi: 10.1210/jc.2013-2254. Epub 2013 Dec 20. J Clin Endocrinol Metab. 2014. PMID: 24187407 Free PMC article.

2

Dopamine agonist therapy and cardiac valve dysfunction.

Sherlock M, Steeds R, Toogood AA. Sherlock M, et al. Clin Endocrinol (Oxf). 2007 Nov;67(5):643-4. doi: 10.1111/j.1365-2265.2007.02974.x. Epub 2007 Jul 20. Clin Endocrinol (Oxf). 2007. PMID: 17645575 No abstract available.

3

Dopamine agonist therapy for hyperprolactinaemia and cardiac valve dysfunction; a lot done but much more to do.

Sherlock M, Toogood AA, Steeds R. Sherlock M, et al. Heart. 2009 Apr;95(7):522-3. doi: 10.1136/hrt.2008.163345. Epub 2009 Jan 27. Heart. 2009. PMID: 19174419 No abstract available.

4

Duration of Diabetes Predicts Aortic Pulse Wave Velocity and Vascular Events in Alström Syndrome.

Paisey RB, Smith J, Carey C, Barrett T, Campbell F, Maffei P, Marshall JD, Paisey C, Steeds RP, Edwards NC, Bunce S, Geberhiwot T. Paisey RB, et al. Among authors: steeds rp. J Clin Endocrinol Metab. 2015 Aug;100(8):E1116-24. doi: 10.1210/jc.2015-1577. Epub 2015 Jun 11. J Clin Endocrinol Metab. 2015. PMID: 26066530 Free PMC article.

5

Effect of Valvular Surgery in Carcinoid Heart Disease: An Observational Cohort Study.

Edwards NC, Yuan M, Nolan O, Pawade TA, Oelofse T, Singh H, Mehrzad H, Zia Z, Geh JI, Palmer DH, May CJ, Ayuk J, Shah T, Rooney SJ, Steeds RP. Edwards NC, et al. Among authors: steeds rp. J Clin Endocrinol Metab. 2016 Jan;101(1):183-90. doi: 10.1210/jc.2015-3295. Epub 2015 Nov 18. J Clin Endocrinol Metab. 2016. PMID: 26580239

6

A Follow-Up Study of the Prevalence of Valvular Heart Abnormalities in Hyperprolactinemic Patients Treated With Cabergoline.

Drake WM, Stiles CE, Bevan JS, Karavitaki N, Trainer PJ, Rees DA, Richardson TI, Baldeweg SE, Stojanovic N, Murray RD, Toogood AA, Martin NM, Vaidya B, Han TS, Steeds RP; UK Cabergoline valvulopathy study group; Baldeweg FC, Sheikh UE, Kyriakakis N, Parasuraman SK, Taylor L, Butt N, Anyiam S. Drake WM, et al. Among authors: steeds rp. J Clin Endocrinol Metab. 2016 Nov;101(11):4189-4194. doi: 10.1210/jc.2016-2224. Epub 2016 Aug 29. J Clin Endocrinol Metab. 2016. PMID: 27571182

7

A meta-analysis of the prevalence of cardiac valvulopathy in hyperprolactinemic patients treated with Cabergoline.

Stiles CE, Tetteh-Wayoe ET, Bestwick J, Steeds RP, Drake WM. Stiles CE, et al. Among authors: steeds rp. J Clin Endocrinol Metab. 2018 Sep 11. doi: 10.1210/jc.2018-01071. Online ahead of print. J Clin Endocrinol Metab. 2018. PMID: 30215804

8

Echocardiography and monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia: A joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology.

Steeds R, Stiles C, Sharma V, Chambers J, Lloyd G, Drake W. Steeds R, et al. Clin Endocrinol (Oxf). 2019 May;90(5):662-669. doi: 10.1111/cen.13940. Epub 2019 Feb 28. Clin Endocrinol (Oxf). 2019. PMID: 30818417

9

Echocardiography and monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia: a joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology.

Steeds RP, Stiles CE, Sharma V, Chambers JB, Lloyd G, Drake W. Steeds RP, et al. Echo Res Pract. 2019 Mar 1;6(1):G1-G8. doi: 10.1530/ERP-18-0069. Echo Res Pract. 2019. PMID: 30825409 Free PMC article.

10

Response to Letter to the Editor: "A Meta-Analysis of the Prevalence of Cardiac Valvulopathy in Patients With Hyperprolactinemia Treated With Cabergoline".

Stiles CE, Steeds RP, Drake WM. Stiles CE, et al. Among authors: steeds rp. J Clin Endocrinol Metab. 2019 Oct 1;104(10):4321-4322. doi: 10.1210/jc.2019-00704. J Clin Endocrinol Metab. 2019. PMID: 30933270 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

308 results

Search Page

Filters